Morgan Stanley
OCEA

Morgan Stanley’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Morgan Stanley’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-399
Closed -$391 – 8141
2024
Q3 		$391 Sell
399
-15,881
-98% -$17K ﹤0.01% 7326
2024
Q2 		$19.9K Sell
16,280
-47,235
-74% -$80.6K ﹤0.01% 6463
2024
Q1 		$240K Buy
63,515
+3,223
+5% +$6.06K ﹤0.01% 5664
2023
Q4 		$39.8K Buy
60,292
+2,932
+5% +$4.02K ﹤0.01% 6235
2023
Q3 		$224K Buy
57,360
+49,689
+648% +$228K ﹤0.01% 5527
2023
Q2 		$46.1K Buy
7,671
+7,527
+5,227% +$44.1K ﹤0.01% 6239
2023
Q1 		$956 Buy
+144
New +$1.22K ﹤0.01% 7363

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley's OCEA Position: Q4 2024 in Review

Morgan Stanley sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q4 2024, closing a stake of 399 shares — an estimated $391 sold.

Morgan Stanley first reported a position in OCEA in Q1 2023 and held it in 7 quarters. The position peaked at $240K in Q1 2024. 22 funds tracked by Wall St. Rank hold OCEA as of Q4 2024.

  • Morgan Stanley reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 399 Ocean Biomedical, Inc. Common Stock shares in Q4 2024, an estimated $391.
  • Morgan Stanley first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
  • Morgan Stanley's Ocean Biomedical, Inc. Common Stock position peaked at $240K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.